These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 16235965)

  • 1. (S)-4-Trimethylsilyl-3-butyn-2-ol as an auxiliary for stereocontrolled synthesis of salinosporamide analogs with modifications at positions C2 and C5.
    Blasdel LK; Lee D; Sun B; Myers AG
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6905-10. PubMed ID: 24269479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal-Free ATRP Catalyzed by Visible Light in Continuous Flow.
    El Achi N; Bakkour Y; Adhami W; Molina J; Penhoat M; Azaroual N; Chausset-Boissarie L; Rolando C
    Front Chem; 2020; 8():740. PubMed ID: 33102428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Dimethylaminopyridine-Catalyzed Metal-Free Aerobic Oxidation of Aryl α-Halo Esters to Aryl α-Keto Esters.
    Jung Y; Hong JE; Baek ST; Hong S; Kwak JH; Park Y
    ACS Omega; 2020 Sep; 5(36):22951-22957. PubMed ID: 32954144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the human proteasome by imidazoline scaffolds.
    Azevedo LM; Lansdell TA; Ludwig JR; Mosey RA; Woloch DK; Cogan DP; Patten GP; Kuszpit MR; Fisk JS; Tepe JJ
    J Med Chem; 2013 Jul; 56(14):5974-8. PubMed ID: 23789888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aryl-2-nitroacetates as central precursors to aryl nitromethanes, α-ketoesters, and α-amino acids.
    Metz AE; Kozlowski MC
    J Org Chem; 2013 Jan; 78(2):717-22. PubMed ID: 23245626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azomethine ylide mediated inversion of configuration of quaternary imidazoline carbon: converting trans- to its cis- imidazolines.
    Qu K; Fisk JS; Tepe JJ
    Tetrahedron Lett; 2011 Sep; 52(38):4840-4842. PubMed ID: 21857756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoline and its derivatives: an overview.
    Tyagi R; Tyagi VK; Pandey SK
    J Oleo Sci; 2007; 56(5):211-22. PubMed ID: 17898484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of MDM2-p53 Inhibitor BI-0282 via a Dipolar Cycloaddition and Late-Stage Davis-Beirut Reaction.
    Ramharter J; Kulhanek M; Dettling M; Gmaschitz G; Karolyi-Oezguer J; Weinstabl H; Gollner A
    Org Process Res Dev; 2022 Aug; 26(8):2526-2531. PubMed ID: 36032359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regioselective synthesis of tetrasubstituted pyrroles by 1,3-dipolar cycloaddition and spontaneous decarboxylation.
    Kim Y; Kim J; Park SB
    Org Lett; 2009 Jan; 11(1):17-20. PubMed ID: 19111057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastereoselective one-pot synthesis of tetrafunctionalized 2-imidazolines.
    Janssen GV; Slobbe P; Mooijman M; Kruithof A; Ehlers AW; Guerra CF; Bickelhaupt FM; Slootweg JC; Ruijter E; Lammertsma K; Orru RV
    J Org Chem; 2014 Jun; 79(11):5219-26. PubMed ID: 24820129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective synthesis of highly substituted Delta1-pyrrolines: exo-selective 1,3-dipolar cycloaddition reactions with azlactones.
    Peddibhotla S; Tepe JJ
    J Am Chem Soc; 2004 Oct; 126(40):12776-7. PubMed ID: 15469263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and diastereoselective ortho-metalation of chiral ferrocenyl imidazolines: remarkable influence of LDA as metalation additive.
    Peters R; Fischer DF
    Org Lett; 2005 Sep; 7(19):4137-40. PubMed ID: 16146371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected ring expansion of an enantiopure imidazoline carbene ligand.
    Pelegrí AS; Elsegood MR; McKee V; Weaver GW
    Org Lett; 2006 Jul; 8(14):3049-51. PubMed ID: 16805549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastereochemical diversity of imidazoline scaffolds via substrate controlled TMSCl mediated cycloaddition of azlactones.
    Sharma V; Tepe JJ
    Org Lett; 2005 Oct; 7(22):5091-4. PubMed ID: 16235965
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.